Related Experiment Videos
Parametric modelling of cost data in medical studies
1Biostatistics Unit, University Forvie Site MRC, Robinson Way, Cambridge CB2 2SR, U.K. richard.nixon@mrc-bsu.cam.ac.uk
Statistics in Medicine
|April 15, 2004
Summary
Analyzing medical cost data requires careful statistical modeling. Skewed parametric distributions often fit better than normal models, but inferences can vary significantly between models, especially with limited data.
Area of Science:
- Health economics
- Biostatistics
- Statistical modeling
Background:
- Medical resource costs are crucial for clinical decision-making.
- Cost data are typically right-skewed, posing challenges for standard statistical inference.
- Common methods for non-normal data are often suboptimal for analyzing skewed cost data.
Purpose of the Study:
- To explore parametric models for analyzing skewed medical cost data.
- To compare the performance of different distributions (normal, gamma, log-normal, log-logistic) in modeling cost data.
- To assess the impact of model choice on population mean cost inferences.
Main Methods:
- Fitting normal, gamma, log-normal, and log-logistic distributions (including three-parameter versions) to four example cost datasets.
- Estimating population mean costs using maximum likelihood.
- Deriving confidence intervals via parametric bootstrap and Markov Chain Monte Carlo (MCMC) methods.
Main Results:
- Skewed parametric distributions generally provide a better fit to cost data than the normal distribution.
- Poorly fitting models can sometimes yield similar inferences to well-fitting ones.
- Different parametric models that fit data equally well can lead to substantially different inferences, particularly with smaller sample sizes.
Conclusions:
- Inferences about population mean cost are sensitive to the chosen statistical model.
- Model uncertainty is significant unless sufficient data are available to accurately model the distribution's tail.
- Sensitivity analyses exploring the impact of model choice are essential when analyzing medical cost data.